FTSE All-Share
|
4 954,56
|
21,33
|
0,43 %
|
Analysen zu FTSE All-Share-Werten
| 21.09.23 | Diageo Overweight | JP Morgan Chase & Co. | |
| 20.09.23 | Glencore Buy | UBS AG | |
| 20.09.23 | National Grid Overweight | JP Morgan Chase & Co. | |
| 18.09.23 | GSK Equal Weight | Barclays Capital | |
| 18.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.09.23 | National Grid Market-Perform | Bernstein Research | |
| 15.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.09.23 | London Stock Exchange Overweight | JP Morgan Chase & Co. | |
| 14.09.23 | BP Buy | UBS AG | |
| 14.09.23 | Vodafone Group Buy | UBS AG | |
| 14.09.23 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 13.09.23 | BAT Buy | UBS AG | |
| 13.09.23 | Diageo Hold | Jefferies & Company Inc. | |
| 13.09.23 | BP Overweight | Barclays Capital | |
| 13.09.23 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.09.23 | BP Outperform | RBC Capital Markets | |
| 13.09.23 | HSBC Holdings Buy | Goldman Sachs Group Inc. | |
| 12.09.23 | BP Overweight | Barclays Capital | |
| 12.09.23 | Prudential Buy | UBS AG | |
| 12.09.23 | GSK Buy | Deutsche Bank AG | |
| 12.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.09.23 | Barclays Overweight | JP Morgan Chase & Co. | |
| 11.09.23 | AstraZeneca Overweight | Barclays Capital | |
| 11.09.23 | BT Group Hold | Deutsche Bank AG | |
| 11.09.23 | National Grid Outperform | RBC Capital Markets | |
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.23 | GSK Buy | Deutsche Bank AG | |
| 08.09.23 | Diageo Sell | Deutsche Bank AG | |
| 08.09.23 | BP Neutral | JP Morgan Chase & Co. | |
| 08.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.09.23 | Diageo Underperform | RBC Capital Markets | |
| 06.09.23 | Unilever Underperform | Bernstein Research | |
| 05.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.09.23 | GSK Buy | Deutsche Bank AG | |
| 05.09.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.09.23 | GSK Equal Weight | Barclays Capital | |
| 01.09.23 | BP Outperform | RBC Capital Markets | |
| 01.09.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 30.08.23 | Anglo American Overweight | Barclays Capital |
HOT STOCKS DER LETZTEN 3 TAGE
| AstraZeneca | 5 |
| Shell | 1 |
| Diageo | 1 |
| National Grid | 1 |
| GSK | 1 |
| London Stock Exchange | 1 |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.